VYNE Annual Total Assets
$97.69 M
+$56.93 M+139.67%
31 December 2023
Summary:
As of January 23, 2025, VYNE annual total assets is $97.69 million, with the most recent change of +$56.93 million (+139.67%) on December 31, 2023. During the last 3 years, it has risen by +$3.94 million (+4.21%). VYNE annual total assets is now -30.19% below its all-time high of $139.93 million, reached on December 31, 2018.VYNE Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VYNE Quarterly Total Assets
$76.20 M
-$10.45 M-12.06%
30 September 2024
Summary:
As of January 23, 2025, VYNE quarterly total assets is $76.20 million, with the most recent change of -$10.45 million (-12.06%) on September 30, 2024. Over the past year, it has dropped by -$10.45 million (-12.06%). VYNE quarterly total assets is now -57.78% below its all-time high of $180.48 million, reached on March 31, 2018.VYNE Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VYNE Total Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +139.7% | -12.1% |
3 y3 years | +4.2% | +87.0% |
5 y5 years | -30.2% | +87.0% |
VYNE Total Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +139.7% | -22.0% | +295.5% |
5 y | 5-year | at high | +139.7% | -52.5% | +295.5% |
alltime | all time | -30.2% | +139.7% | -57.8% | +295.5% |
VYNE Therapeutics Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $76.20 M(-12.1%) |
June 2024 | - | $86.65 M(-5.5%) |
Mar 2024 | - | $91.68 M(-6.2%) |
Dec 2023 | $97.69 M(+139.7%) | $97.69 M(+407.0%) |
Sept 2023 | - | $19.27 M(-22.8%) |
June 2023 | - | $24.96 M(-29.2%) |
Mar 2023 | - | $35.26 M(-13.5%) |
Dec 2022 | $40.76 M(-39.2%) | $40.76 M(-13.1%) |
Sept 2022 | - | $46.91 M(-15.0%) |
June 2022 | - | $55.19 M(-14.2%) |
Mar 2022 | - | $64.32 M(-4.1%) |
Dec 2021 | $67.05 M(-28.5%) | $67.05 M(-17.5%) |
Sept 2021 | - | $81.31 M(-39.3%) |
June 2021 | - | $133.98 M(-10.2%) |
Mar 2021 | - | $149.17 M(+59.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2020 | $93.74 M(+18.4%) | $93.74 M(-12.9%) |
Sept 2020 | - | $107.68 M(-17.7%) |
June 2020 | - | $130.84 M(-18.5%) |
Mar 2020 | - | $160.53 M(+102.8%) |
Dec 2019 | $79.17 M(-43.4%) | $79.17 M(-18.0%) |
Sept 2019 | - | $96.58 M(-15.6%) |
June 2019 | - | $114.38 M(-9.4%) |
Mar 2019 | - | $126.26 M(-9.8%) |
Dec 2018 | $139.93 M(+109.3%) | $139.93 M(-9.7%) |
Sept 2018 | - | $154.96 M(-7.2%) |
June 2018 | - | $166.92 M(-7.5%) |
Mar 2018 | - | $180.48 M(+169.9%) |
Dec 2017 | $66.87 M(+59.0%) | $66.87 M(-11.8%) |
Sept 2017 | - | $75.80 M(+80.2%) |
Dec 2016 | $42.05 M(-4.2%) | $42.05 M |
Dec 2015 | $43.88 M | - |
FAQ
- What is VYNE Therapeutics annual total assets?
- What is the all time high annual total assets for VYNE Therapeutics?
- What is VYNE Therapeutics annual total assets year-on-year change?
- What is VYNE Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly total assets year-on-year change?
What is VYNE Therapeutics annual total assets?
The current annual total assets of VYNE is $97.69 M
What is the all time high annual total assets for VYNE Therapeutics?
VYNE Therapeutics all-time high annual total assets is $139.93 M
What is VYNE Therapeutics annual total assets year-on-year change?
Over the past year, VYNE annual total assets has changed by +$56.93 M (+139.67%)
What is VYNE Therapeutics quarterly total assets?
The current quarterly total assets of VYNE is $76.20 M
What is the all time high quarterly total assets for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly total assets is $180.48 M
What is VYNE Therapeutics quarterly total assets year-on-year change?
Over the past year, VYNE quarterly total assets has changed by -$10.45 M (-12.06%)